GENINCODE PLC

• ⚠

  Material uncertainty over going concern

  We draw attention to note 2 in the financial statements, which indicates that the Group and Parent Company may require further funding if there are delays in the forecast revenue growth which could impact the Group's liquidity. Given the uncertainty of these matters this, along with the other matters as set forth in note 2, indicate the existence of a material uncertainty which may cast significant doubt about the Group's and Parent Company's ability to continue as a going concern.

1. GENINCODE PLC 2021-07-16 → present
2. GENINCODE LIMITED 2021-07-13 → 2021-07-16
3. GENINCODE UK LIMITED 2018-09-06 → 2021-07-13

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

IFRS

Reporting scope

Consolidated group

Auditor

Crowe U.K. LLP

Audit opinion

Unqualified (clean)

Going concern

Material uncertainty disclosed

“We draw attention to note 2 in the financial statements, which indicates that the Group and Parent Company may require further funding if there are delays in the forecast revenue growth which could impact the Group's liquidity. Given the uncertainty of these matters this, along with the other matters as set forth in note 2, indicate the existence of a material uncertainty which may cast significant doubt about the Group's and Parent Company's ability to continue as a going concern.”

Group structure

1. GENINCODE PLC · parent
   1. GENinCode S.L.U. 100% · Spain · Medical and scientific research
   2. GENinCode U.S. INC. 100% · USA · Medical and scientific research
   3. GENinCode UK Ltd 100% · England & Wales · Dormant company
   4. Abcodia Ltd 100% · England & Wales · Medical and scientific research
   5. Abcodia UK Ltd 100% · England & Wales · Dormant company
   6. Abcodia CS Ltd 100% · England & Wales · Dormant company
   7. Abcodia Inc 100% · USA · Dormant company

Significant events

• “On 3 March 2025 the Company issued 109,917,616 shares at a price of 3.7 pence per share as a result of a fund raising of £4.1m in capital for the Group. A total of 4,662,162 shares were issued to the Directors of the Group under the same terms.”
• “On 26 March 2025, the Company announced that it had approved and granted (on 21 March 2025) new options over an aggregate of 14,028,305 new ordinary shares of 1 pence each in the Company to certain directors and employees of the Company, representing 4.89 per cent. of the Company's existing share capital; the new options have an exercise price of 3.7 pence per share and are exercisable on the second anniversary of the date of grant. Following the grant of the new options and the options surrender, there are options over a total of 32,915,560 ordinary shares in the Company.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

5

last 12 months

Capital events

2

last 24 months

Officers appointed

0

last 12 months

Officers resigned

0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  +25%

  £2,160,000 → £2,701,000

• Cash

  -55.3%

  £2,484,000 → £1,110,000

• Net assets

  -12.6%

  £1,289,000 → £1,127,000

• Employees

  0%

  42 → 42

• Operating profit

  +28.2%

  -£7,151,000 → -£5,134,000

• Profit before tax

  +27.6%

  -£7,023,000 → -£5,083,000

• Wages

  -4.9%

  £2,779,000 → £2,644,000

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers